These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21981246)

  • 1. The atypical cannabinoid O-1602 stimulates food intake and adiposity in rats.
    Díaz-Arteaga A; Vázquez MJ; Vazquez-Martínez R; Pulido MR; Suarez J; Velásquez DA; López M; Ross RA; de Fonseca FR; Bermudez-Silva FJ; Malagón MM; Diéguez C; Nogueiras R
    Diabetes Obes Metab; 2012 Mar; 14(3):234-43. PubMed ID: 21981246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the putative cannabinoid receptor (GPR55)-mediated inhibitory effects on intestinal contractility in mice.
    Ross GR; Lichtman A; Dewey WL; Akbarali HI
    Pharmacology; 2012; 90(1-2):55-65. PubMed ID: 22759743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment.
    Schicho R; Bashashati M; Bawa M; McHugh D; Saur D; Hu HM; Zimmer A; Lutz B; Mackie K; Bradshaw HB; McCafferty DM; Sharkey KA; Storr M
    Inflamm Bowel Dis; 2011 Aug; 17(8):1651-64. PubMed ID: 21744421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans.
    Romero-Zerbo SY; Rafacho A; Díaz-Arteaga A; Suárez J; Quesada I; Imbernon M; Ross RA; Dieguez C; Rodríguez de Fonseca F; Nogueiras R; Nadal A; Bermúdez-Silva FJ
    J Endocrinol; 2011 Nov; 211(2):177-85. PubMed ID: 21885477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans.
    Liu B; Song S; Ruz-Maldonado I; Pingitore A; Huang GC; Baker D; Jones PM; Persaud SJ
    Diabetes Obes Metab; 2016 Dec; 18(12):1263-1273. PubMed ID: 27561953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects.
    Johns DG; Behm DJ; Walker DJ; Ao Z; Shapland EM; Daniels DA; Riddick M; Dowell S; Staton PC; Green P; Shabon U; Bao W; Aiyar N; Yue TL; Brown AJ; Morrison AD; Douglas SA
    Br J Pharmacol; 2007 Nov; 152(5):825-31. PubMed ID: 17704827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation.
    Zhang L; Lee NJ; Nguyen AD; Enriquez RF; Riepler SJ; Stehrer B; Yulyaningsih E; Lin S; Shi YC; Baldock PA; Herzog H; Sainsbury A
    Diabetes Obes Metab; 2010 Jul; 12(7):591-603. PubMed ID: 20590734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphenol A induces hypothalamic down-regulation of the the cannabinoid receptor 1 and anorexigenic effects in male mice.
    Suglia A; Chianese R; Migliaccio M; Ambrosino C; Fasano S; Pierantoni R; Cobellis G; Chioccarelli T
    Pharmacol Res; 2016 Nov; 113(Pt A):376-383. PubMed ID: 27641926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis.
    Cota D; Marsicano G; Tschöp M; Grübler Y; Flachskamm C; Schubert M; Auer D; Yassouridis A; Thöne-Reineke C; Ortmann S; Tomassoni F; Cervino C; Nisoli E; Linthorst AC; Pasquali R; Lutz B; Stalla GK; Pagotto U
    J Clin Invest; 2003 Aug; 112(3):423-31. PubMed ID: 12897210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAPK.
    Schmuhl E; Ramer R; Salamon A; Peters K; Hinz B
    Biochem Pharmacol; 2014 Feb; 87(3):489-501. PubMed ID: 24304686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells.
    Chiba T; Ueno S; Obara Y; Nakahata N
    J Pharm Pharmacol; 2011 May; 63(5):636-47. PubMed ID: 21492165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of G-protein-coupled receptor 55 promotes obesity by reducing physical activity.
    Meadows A; Lee JH; Wu CS; Wei Q; Pradhan G; Yafi M; Lu HC; Sun Y
    Int J Obes (Lond); 2016 Mar; 40(3):417-24. PubMed ID: 26447738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between orexin A and cannabinoid system in the lateral hypothalamus of rats and effects of subchronic intraperitoneal administration of cannabinoid receptor inverse agonist on food intake and the nutritive utilization of protein.
    Merroun I; El Mlili N; Martinez R; Porres JM; Llopis J; Ahabrach H; Aranda P; Sanchez Gonzalez C; Errami M; Lopez-Jurado M
    J Physiol Pharmacol; 2015 Apr; 66(2):181-90. PubMed ID: 25903949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues.
    Lipina C; Walsh SK; Mitchell SE; Speakman JR; Wainwright CL; Hundal HS
    FASEB J; 2019 Jan; 33(1):1299-1312. PubMed ID: 30148676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells.
    Chiurchiù V; Lanuti M; De Bardi M; Battistini L; Maccarrone M
    Int Immunol; 2015 Mar; 27(3):153-60. PubMed ID: 25344934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin-regulated endocannabinoids are involved in maintaining food intake.
    Di Marzo V; Goparaju SK; Wang L; Liu J; Bátkai S; Járai Z; Fezza F; Miura GI; Palmiter RD; Sugiura T; Kunos G
    Nature; 2001 Apr; 410(6830):822-5. PubMed ID: 11298451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of Gpr55 Results in Subtle Effects on Energy Metabolism, Motor Activity and Thermal Pain Sensation.
    Bjursell M; Ryberg E; Wu T; Greasley PJ; Bohlooly-Y M; Hjorth S
    PLoS One; 2016; 11(12):e0167965. PubMed ID: 27941994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive effects of olanzapine and melanin-concentrating hormone agonism on energy balance.
    Guesdon B; Denis RG; Richard D
    Behav Brain Res; 2010 Feb; 207(1):14-20. PubMed ID: 19788900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of GPR55, a putative cannabinoid receptor.
    Sharir H; Abood ME
    Pharmacol Ther; 2010 Jun; 126(3):301-13. PubMed ID: 20298715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KBP-088, a novel DACRA with prolonged receptor activation, is superior to davalintide in terms of efficacy on body weight.
    Gydesen S; Andreassen KV; Hjuler ST; Christensen JM; Karsdal MA; Henriksen K
    Am J Physiol Endocrinol Metab; 2016 May; 310(10):E821-7. PubMed ID: 26908506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.